Literature DB >> 19437497

Fully automatic hippocampus segmentation and classification in Alzheimer's disease and mild cognitive impairment applied on data from ADNI.

Marie Chupin1, Emilie Gérardin, Rémi Cuingnet, Claire Boutet, Louis Lemieux, Stéphane Lehéricy, Habib Benali, Line Garnero, Olivier Colliot.   

Abstract

The hippocampus is among the first structures affected in Alzheimer's disease (AD). Hippocampal magnetic resonance imaging volumetry is a potential biomarker for AD but is hindered by the limitations of manual segmentation. We proposed a fully automatic method using probabilistic and anatomical priors for hippocampus segmentation. Probabilistic information is derived from 16 young controls and anatomical knowledge is modeled with automatically detected landmarks. The results were previously evaluated by comparison with manual segmentation on data from the 16 young healthy controls, with a leave-one-out strategy, and eight patients with AD. High accuracy was found for both groups (volume error 6 and 7%, overlap 87 and 86%, respectively). In this article, the method was used to segment 145 patients with AD, 294 patients with mild cognitive impairment (MCI), and 166 elderly normal subjects from the Alzheimer's Disease Neuroimaging Initiative database. On the basis of a qualitative rating protocol, the segmentation proved acceptable in 94% of the cases. We used the obtained hippocampal volumes to automatically discriminate between AD patients, MCI patients, and elderly controls. The classification proved accurate: 76% of the patients with AD and 71% of the MCI converting to AD before 18 months were correctly classified with respect to the elderly controls, using only hippocampal volume. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19437497      PMCID: PMC2837195          DOI: 10.1002/hipo.20626

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  21 in total

1.  Automated hippocampal segmentation by regional fluid registration of serial MRI: validation and application in Alzheimer's disease.

Authors:  W R Crum; R I Scahill; N C Fox
Journal:  Neuroimage       Date:  2001-05       Impact factor: 6.556

2.  Elastic model-based segmentation of 3-D neuroradiological data sets.

Authors:  A Kelemen; G Székely; G Gerig
Journal:  IEEE Trans Med Imaging       Date:  1999-10       Impact factor: 10.048

3.  Measuring size and shape of the hippocampus in MR images using a deformable shape model.

Authors:  Dinggang Shen; Scott Moffat; Susan M Resnick; Christos Davatzikos
Journal:  Neuroimage       Date:  2002-02       Impact factor: 6.556

4.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

5.  Appearance-based segmentation of medial temporal lobe structures.

Authors:  S Duchesne; J Pruessner; D L Collins
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

Review 6.  Staging of Alzheimer's disease-related neurofibrillary changes.

Authors:  H Braak; E Braak
Journal:  Neurobiol Aging       Date:  1995 May-Jun       Impact factor: 4.673

7.  Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Dementia of the Alzheimer type.

Authors:  J G Csernansky; L Wang; S Joshi; J P Miller; M Gado; D Kido; D McKeel; J C Morris; M I Miller
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

8.  Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia.

Authors:  Yuan-Yu Hsu; Norbert Schuff; An-Tao Du; Kevin Mark; Xiaoping Zhu; Dawn Hardin; Michael W Weiner
Journal:  J Magn Reson Imaging       Date:  2002-09       Impact factor: 4.813

9.  Hippocampus and entorhinal cortex in mild cognitive impairment and early AD.

Authors:  Corina Pennanen; Miia Kivipelto; Susanna Tuomainen; Päivi Hartikainen; Tuomo Hänninen; Mikko P Laakso; Merja Hallikainen; Matti Vanhanen; Aulikki Nissinen; Eeva-Liisa Helkala; Pauli Vainio; Ritva Vanninen; Kaarina Partanen; Hilkka Soininen
Journal:  Neurobiol Aging       Date:  2004-03       Impact factor: 4.673

10.  Automatic segmentation of the hippocampus and the amygdala driven by hybrid constraints: method and validation.

Authors:  M Chupin; A Hammers; R S N Liu; O Colliot; J Burdett; E Bardinet; J S Duncan; L Garnero; L Lemieux
Journal:  Neuroimage       Date:  2009-02-21       Impact factor: 6.556

View more
  92 in total

Review 1.  The Alzheimer's disease neuroimaging initiative: progress report and future plans.

Authors:  Michael W Weiner; Paul S Aisen; Clifford R Jack; William J Jagust; John Q Trojanowski; Leslie Shaw; Andrew J Saykin; John C Morris; Nigel Cairns; Laurel A Beckett; Arthur Toga; Robert Green; Sarah Walter; Holly Soares; Peter Snyder; Eric Siemers; William Potter; Patricia E Cole; Mark Schmidt
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

2.  Characterizing Alzheimer's disease using a hypometabolic convergence index.

Authors:  Kewei Chen; Napatkamon Ayutyanont; Jessica B S Langbaum; Adam S Fleisher; Cole Reschke; Wendy Lee; Xiaofen Liu; Dan Bandy; Gene E Alexander; Paul M Thompson; Leslie Shaw; John Q Trojanowski; Clifford R Jack; Susan M Landau; Norman L Foster; Danielle J Harvey; Michael W Weiner; Robert A Koeppe; William J Jagust; Eric M Reiman
Journal:  Neuroimage       Date:  2011-01-27       Impact factor: 6.556

Review 3.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

Review 4.  Integrating ADNI results into Alzheimer's disease drug development programs.

Authors:  Jeffrey L Cummings
Journal:  Neurobiol Aging       Date:  2010-05-05       Impact factor: 4.673

5.  Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort.

Authors:  Shannon L Risacher; Li Shen; John D West; Sungeun Kim; Brenna C McDonald; Laurel A Beckett; Danielle J Harvey; Clifford R Jack; Michael W Weiner; Andrew J Saykin
Journal:  Neurobiol Aging       Date:  2010-08       Impact factor: 4.673

6.  Mild cognitive impairment: differential atrophy in the hippocampal subfields.

Authors:  B J Hanseeuw; K Van Leemput; M Kavec; C Grandin; X Seron; A Ivanoiu
Journal:  AJNR Am J Neuroradiol       Date:  2011-08-11       Impact factor: 3.825

7.  Fast and robust extraction of hippocampus from MR images for diagnostics of Alzheimer's disease.

Authors:  Jyrki Lötjönen; Robin Wolz; Juha Koikkalainen; Valtteri Julkunen; Lennart Thurfjell; Roger Lundqvist; Gunhild Waldemar; Hilkka Soininen; Daniel Rueckert
Journal:  Neuroimage       Date:  2011-01-31       Impact factor: 6.556

8.  Prediction of Alzheimer's disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning.

Authors:  Simon F Eskildsen; Pierrick Coupé; Daniel García-Lorenzo; Vladimir Fonov; Jens C Pruessner; D Louis Collins
Journal:  Neuroimage       Date:  2012-10-02       Impact factor: 6.556

9.  The anteroposterior and primary-to-posterior limbic ratios as MRI-derived volumetric markers of Alzheimer's disease.

Authors:  Adolfo Jiménez-Huete; Susana Estévez-Santé
Journal:  J Neurol Sci       Date:  2017-04-27       Impact factor: 3.181

10.  Biomarkers for the clinical evaluation of the cognitively impaired elderly: amyloid is not enough.

Authors:  Linda K McEvoy; James B Brewer
Journal:  Imaging Med       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.